Skip to content

Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)

Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04219800
Acronym
ROSEBUD
Enrollment
46
Registered
2020-01-07
Start date
2020-12-08
Completion date
2024-12-30
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

Type 2 diabetes mellitus (T2DM) patients are suboptimal treated due to low uptake of physical activity. Recent research shows promising beneficial health effects from reducing sitting time by regular short bouts of light-intensity physical activity. These findings open up for a new focus in T2DM treatment but conclusive evidence is missing as studies have been short-term trials, mainly conducted in laboratory environments. Recent research suggest that reduced sitting and increased physical activity can be supported at a low cost by mHealth (mobile health) technology such as activity tracker armbands that warns of prolonged sitting and SMS text messages that reminds of activity breaks. The overarching purpose of the project is to evaluate the effects of an intervention aimed to reduce occupational sitting in T2DM using mHealth (mobile health). It is hypothesized that the intervention will lead to (1) Activity changes - reduced sitting time and/or increased number of steps (primary outcome measures) and (2) Health effects - lower fatigue, improved health-related quality of life, reduced cardiometabolic risk, less sick leave, less medication, less musculoskeletal problems (secondary outcome measures)

Interventions

BEHAVIORALPatient-centered counselling and written material

Patient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.

BEHAVIORALmHealth

1. Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps. 2. SMS text messages; reminds of activity breaks. 3. Mobile video instruction for standing pause gymnastics.

Sponsors

Umeå University
Lead SponsorOTHER
Norrbottens County Council
CollaboratorOTHER_GOV
Vastra Gotaland Region
CollaboratorOTHER_GOV
Region Östergötland
CollaboratorOTHER
Region Stockholm
CollaboratorOTHER_GOV
Region Örebro County
CollaboratorOTHER
Region Västerbotten
CollaboratorOTHER_GOV
Region Jämtland Härjedalen
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 Diabetes Melltitus * 40-64 years * HbA1c 48-100 mmol/mol * BMI ≥ 25 kg/m2 * Working at least 75% of full-time in a mainly seated job.

Exclusion criteria

* Pregnancy * Regular vigorous intensity exercise * Severe disease or for other reason unable to follow the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Sitting time12 monthsAssessed by activPAL3 thigh-worn accelerometer

Secondary

MeasureTime frameDescription
Steps12 monthsAssessed by activPAL3 thigh-worn accelerometer
Fatigue12 monthsMFI-20 questionnaire
Health-related quality of life12 monthsRAND-36 questionnaire
Cardiometabolic composite score (CCMR)12 monthsWill be determined by summing z-scores (\[value-mean\]/SD) of waist circumference (cm), mean arterial pressure (mmHg), HbA1c (mmol/mol), the inverse of HDL (mmol/L) and triglycerides (mmol/L), using sex-specific means and SDs
Sick leave12 monthsAssessed by diary
Medications12 monthsTotal use of medications
Musculoskeletal problems12 monthsNRS questionnaire

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORPatrik Wennberg

Umeå University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026